or Try an Advanced Search...

    Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.62 0.49% 0.00
    VRPX closed down 6.66 percent on Wednesday, November 20, 2024, on 1.34 times normal volume. It ran into resistance at its 50 day moving average.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical VRPX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.49%
    50 DMA Resistance Bearish 0.49%
    Expansion Pivot Sell Setup Bearish Swing Setup 0.49%
    Outside Day Range Expansion 0.49%
    Gapped Up Strength 0.49%
    Lower Bollinger Band Touch Weakness 0.49%
    Fell Below 20 DMA Bearish -6.20%
    Fell Below 50 DMA Bearish -6.20%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.20%
    Spinning Top Other -6.20%
    Older End-of-Day Signals for VRPX ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance about 1 hour ago
    10 DMA Resistance about 1 hour ago
    Up 5% about 1 hour ago
    Up 3% about 1 hour ago
    Up 2% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    VRPX Chart by TradingView
    Basic chart:

    Profile

    Virpax Pharmaceuticals, Inc. Description

    Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pain Health Sciences Drugs Euphoriants Opioids Influenza Pain Management Drug Delivery Analgesics Morphinans Post Traumatic Stress Disorder Heroin Drug Delivery Systems Morphine Bupivacaine Nasal Administration

    Is VRPX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
    Aug 13 Virpax Pharmaceuticals GAAP EPS of -$1.75
    Aug 13 Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
    Jul 29 Virpax Pharmaceuticals files to sell common stock, warrants
    Jul 24 Virpax regains compliance with Nasdaq minimum bid price
    Jul 24 Virpax Regains Compliance with Nasdaq Minimum Bid Price
    Jul 12 Latest Cannabis Hires And Board Changes, Here's What You Need To Know
    Jul 10 Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Jul 10 Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?
    Jul 10 Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™
    See more VRPX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.507
    52 Week Low 0.3625
    Average Volume 205,905
    200-Day Moving Average 1.73
    50-Day Moving Average 0.66
    20-Day Moving Average 0.68
    10-Day Moving Average 0.67
    Average True Range 0.08
    RSI (14) 44.75
    ADX 16.98
    +DI 19.46
    -DI 21.61
    Chandelier Exit (Long, 3 ATRs) 0.54
    Chandelier Exit (Short, 3 ATRs) 0.80
    Upper Bollinger Bands 0.78
    Lower Bollinger Band 0.58
    Percent B (%b) 0.18
    BandWidth 28.78
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0062
    Fundamentals Value
    Market Cap 7.23 Million
    Num Shares 11.7 Million
    EPS -1.17
    Price-to-Earnings (P/E) Ratio -0.53
    Price-to-Sales 0.00
    Price-to-Book 0.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.81
    Resistance 3 (R3) 0.82 0.76 0.78
    Resistance 2 (R2) 0.76 0.72 0.76 0.77
    Resistance 1 (R1) 0.69 0.69 0.66 0.68 0.76
    Pivot Point 0.64 0.64 0.62 0.63 0.64
    Support 1 (S1) 0.56 0.59 0.54 0.55 0.48
    Support 2 (S2) 0.51 0.56 0.50 0.47
    Support 3 (S3) 0.43 0.51 0.46
    Support 4 (S4) 0.43